skip to content

Maxwell Centre








Latest news

Impulse Alum Cellestial Health Secures Pre-Seed Funding to Advance Innovative Astrocyte-Targeting Therapies for Brain Disorders

13 May 2025

Cellestial Health, a pioneering pharmaceutical development spin-out from the University of Cambridge, has closed a £515,000 pre-seed equity funding round to accelerate the development of novel therapeutics targeting astrocytes, an often-overlooked cell type in the brain, with the first indication of Parkinson’s disease...